C18:1 Galactosyl(β) Ceramide (d18:1/18:1(9Z))
| Catalog Number | BL-M001139 |
| CAS Number | 73039-25-5 |
| Description | C18:1 Galactosyl(β) Ceramide (d18:1/18:1(9Z)): Used in the treatment of disorders related to sphingolipid metabolism, including Niemann-Pick disease type C and Farber disease. Also studied for its potential in cancer therapy due to its role in cell signaling pathways. |
 | |
| IUPAC Name | (E)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]octadec-9-enamide |
| Synonyms | D-galactosyl-β-1,1'-N-oleoyl-D-erythro-sphingosine; C18:1 β-D-galactosyl ceramide; N-(9Z-octadecenoyl)-1-β-galactosyl-sphing-4-enine; GalCer(d18:1/18:1(9Z)) |
| Molecular Weight | 726.08 |
| Molecular Formula | C42H79NO8 |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 69.48%, H 10.97%, N 1.93%, O 17.63% |
| Canonical SMILES | CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)NC(=O)CCCCCCCC=CCCCCCCCC)O |
| InChI | InChI=1S/C42H79NO8/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-38(46)43-35(34-50-42-41(49)40(48)39(47)37(33-44)51-42)36(45)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,29,31,35-37,39-42,44-45,47-49H,3-16,19-28,30,32-34H2,1-2H3,(H,43,46)/b18-17+,31-29+ |
| InChI Key | MVGFIPNJBNBHNC-LSUSWXEESA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
